Tang Li-da

Statistics

Publications

Citations

208

H-Index

Active since

2011

Affiliations

Tianjin Institute of Pharmaceutical Research (China)(Current)

Tianjin Medical University

University of California, San Francisco

Case Western Reserve University

Tang Li-da is an author at Tianjin Institute of Pharmaceutical Research (China) specializing in pharmacology, tyrosine kinase inhibitors, and drug discovery.

Publications per year

2011–2020

Publications

Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (<i>PTPN11</i>)

Wei Liu, Bing Yu, Gang Xu et al. · Journal of Medicinal Chemistry · 2013 · 71 citations · Full text

Medicine, Oncology, Pharmacology +11

Targeting Protein Tyrosine Phosphatase SHP2 for the Treatment of <i>PTPN11</i> -Associated Malignancies

Bing Yu, Wei Liu, Wen-Mei Yu et al. · Molecular Cancer Therapeutics · 2013 · 44 citations

Life Sciences, Molecular Biology, Pharmacology +17

Docking and Molecular Dynamics Simulations of Peroxisome Proliferator Activated Receptors Interacting with Pan Agonist Sodelglitazar

Xuyuan Liu, Run‐Ling Wang, Weiren Xu et al. · Protein and Peptide Letters · 2011 · 27 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis and antitumor activity of 4-aminoquinazoline derivatives targeting VEGFR-2 tyrosine kinase

Bing Yu, Tang Li-da, Yiliang Li et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Effect of human recombinant prourokinase(rhpro-UK) on thromboembolic stroke in rats

Chunhua Hao, Wen-Xia Ding, Qian Sun et al. · European Journal of Pharmacology · 2017 · 15 citations

Medicine, Neurology, Pharmacology +12

1–5 of 7